---
layout: minimal
nav_exclude: true
title: Adalimumab 40mg
---

# Adalimumab 40mg

**Generic Name:** Adalimumab

**Usage:** Adalimumab is a tumor necrosis factor (TNF) blocker used to treat various inflammatory conditions.  Its specific uses vary slightly depending on the formulation and approval in different countries, but generally include:

* **Rheumatoid arthritis (RA):**  Reduces signs and symptoms, slows joint damage, and improves physical function.
* **Psoriatic arthritis:** Reduces signs and symptoms, improves physical function, and slows joint damage.
* **Ankylosing spondylitis:** Reduces signs and symptoms.
* **Psoriasis (plaque):** Clears skin lesions.
* **Hidradenitis suppurativa (HS):** Reduces the number and severity of lesions.
* **Crohn's disease:** Reduces signs and symptoms and promotes remission.
* **Ulcerative colitis:** Reduces signs and symptoms and promotes remission.
* **Juvenile idiopathic arthritis (JIA):** Reduces signs and symptoms.
* **Uveitis:** Reduces inflammation in the eye.


**Side Effects:**  Like all medications, adalimumab can cause side effects.  These can range from mild to severe.  Common side effects include:

* **Injection site reactions:** Redness, pain, swelling, itching at the injection site.
* **Infections:** Increased risk of infections (upper respiratory tract infections, skin infections, etc.).  Serious infections are possible.
* **Headache:**
* **Nausea:**
* **Fatigue:**
* **Rash:**
* **Allergic reactions:**  In rare cases, serious allergic reactions can occur.

**Less common, but more serious side effects include:**

* **Heart failure:**
* **Blood disorders:**  Decreased blood cell counts.
* **Nervous system problems:**  Numbness, tingling, vision changes.
* **Liver problems:**  Elevated liver enzymes.
* **Lupus-like syndrome:**
* **Multiple sclerosis:**
* **Lymphoma and other cancers:** Increased risk, particularly in patients with pre-existing risk factors.


**How it Works:** Adalimumab is a monoclonal antibody that targets and neutralizes tumor necrosis factor-alpha (TNF-α). TNF-α is a protein involved in inflammation. By blocking TNF-α, adalimumab reduces the inflammatory response that underlies many autoimmune and inflammatory diseases.


**FAQs:**

* **How is adalimumab administered?**  It's administered by subcutaneous injection (under the skin), usually at home.
* **How often is adalimumab injected?** The frequency of injections varies depending on the condition being treated and the patient's response.  It can range from every other week to once a month.
* **Are there any drug interactions?** Yes, there are potential interactions with other medications, particularly those that suppress the immune system.  It's crucial to inform your doctor about all medications you are taking.
* **Who shouldn't take adalimumab?** People with active infections, severe heart failure, or certain other medical conditions may not be suitable candidates.  Pregnant or breastfeeding women should discuss the risks and benefits with their doctor.
* **What are the long-term effects of adalimumab?** Long-term use can increase the risk of certain infections and other serious side effects.  Regular monitoring by a doctor is essential.
* **What should I do if I experience side effects?**  Contact your doctor immediately if you experience any concerning side effects.

**Disclaimer:** This information is for general knowledge only and does not constitute medical advice.  Always consult with a healthcare professional before starting or changing any medication, including adalimumab.  They can assess your individual health needs and determine the appropriate dosage and treatment plan.  The specific side effects and risks may vary depending on the individual and the specific condition being treated.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.